Joseph Dignazio

Joseph Dignazio is a Private Equity Analyst at Graham Partners, a position held since August 2022, following a previous role as a Private Equity Summer Analyst at the same firm in 2021. Dignazio's experience includes a role as a Spring Corporate Development Analyst at TerrAscend, where participation in the acquisition of Keystone Canna Remedies occurred. Prior to this, Dignazio served as Director of Portfolio Analytics and Associate Analyst in the Healthcare Sector at Leveraged Lion Capital, focusing on high-yield credit analysis. Additional experience includes positions at Quarrel Capital Ventures as an Angel Investor, Zelira Therapeutics as a Summer Valuation Analyst, Ilera Healthcare as a Summer Finance & Sales Analytics Intern, and Sealed Air Corporation as an Operational Excellence Senior Project intern. Dignazio earned a Bachelor of Science in Industrial Engineering and a minor in Economics from Penn State University, after graduating from The Haverford School.